BICX

$0.22+0.00%

BioCorRx Inc.

Market Cap

$7M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.10

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

8.3

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	635	(151)	215	88	787
Cost of revenue			25	145
Research & development	1,005	306	352	712	2,375
Selling, general & administrative	1,145	539	775	686	3,146
Total operating expenses	2,581	383	1,171	1,554	5,688
Operating income	(1,946)	(534)	(956)	(1,466)	(4,901)
Interest expense	30	70	31	30	161
Pretax income	(809)	(471)	(860)	(1,002)	(3,141)
Income tax			0.00	0.00
Net income	(1,918)	553	(831)	(965)	(3,161)
EPS (diluted) ($)	(0.06)		(0.03)	(0.03)	—
Weighted avg. shares (diluted)	32,289		25,600	29,220

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 4, 2026 accepted 9:53 AM ET	5.02Officer / director change	Document SEC ↗
Apr 2, 2026 accepted 3:31 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Aug 1, 2025 accepted 4:15 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Mar 11, 2025 accepted 1:43 PM ET	1.01Material agreement3.02Unregistered equity sale8.01Other events	Document SEC ↗